CT048 / CARsgen - LARVOL DELTA

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors (clinicaltrials.gov) - P1 | N=63 | Recruiting | Sponsor: Peking University | Not yet recruiting ➔ Recruiting

CAR T-Cell Therapy • Enrollment open • Metastases • Esophageal Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor • CLDN18

"Carsgen has an armored CT041 version, secreting IL-7 and CCL21 (CT048). The phase 1/2 is ongoing, hopefully they release some data soon" (@leochicaybam)

P1/2 data • CCL21 • IL7

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors (clinicaltrials.gov) - P1 | N=63 | Not yet recruiting | Sponsor: Peking University

CAR T-Cell Therapy • New P1 trial • Esophageal Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor • CLDN18